DOI QR코드

DOI QR Code

Clinical Significance of Serum Amylase Measurement in Sjögren's Syndrome

쇼그렌 증후군에서 혈청 amylase 측정의 임상적 의의

  • Nam, Eon Jeong (Department of Internal Medicine, School of Medicine, Kyungpook National University) ;
  • Lee, Nan Young (Department of Clinical Pathology, School of Medicine, Kyungpook National University)
  • 남언정 (경북대학교 의과대학 내과학교실) ;
  • 이난영 (경북대학교 의과대학 임상병리학교실)
  • Received : 2021.02.17
  • Accepted : 2021.06.04
  • Published : 2021.06.30

Abstract

Serum amylase is a representative enzyme secreted by the salivary gland and pancreas. This study investigates the clinical significance of serum amylase levels in Sjögren's syndrome (SS). Totally, 70 female subjects were enrolled, who were diagnosed as SS and had no accompanying afflictions that affected the serum amylase levels. Unstimulated salivary flow rate (U-SFR) and stimulated SFR (S-SFR), salivary gland scan, and disease activity markers (ESSDAI and ESSPRI), as well as blood tests including ESR, CRP, and amylase, were evaluated. Serum amylase showed significant positive correlation with the U-SFR and S-SFR, and was increased with higher ejection fraction (EF) of the parotid gland. However, there was no significant correlation with disease activity and inflammatory markers. Based on their average amylase levels, subjects were divided into two groups. The group with higher serum amylase levels showed a statistically significant increase in the S-SFR and EF of the parotid gland. Considering the results of the salivary gland scan, we conclude that serum amylase is significantly correlated with SFR and the EF of the parotid gland, thereby indicating that the salivary gland function remains intact in SS.

혈청 amylase는 침샘 및 췌장에서 주로 분비되는 대표적인 효소로 침샘의 염증으로 인한 침샘 기능 저하와 질병 활성도는 혈청 amylase에 영향을 미칠 가능성이 있어, 쇼그렌 증후군에서 이들의 상관관계를 분석함으로써 혈청 amylase 측정의 임상적 의의를 알아보고자 하였다. 쇼그렌 증후군으로 진단받았으나, 혈청 amylase치에 영향을 미치는 동반 질환이 없는 여자 환자 70명을 대상으로 하였으며, 비자극 침샘 유속(U-SFR)과 자극 침샘 유속(S-SFR), 침샘 스캔 검사, 질병 활성도 표지자(ESSDAI와 ESSPRI), 혈액검사로 자가항체, 면역글로불린, amylase, 염증 표지자 검사를 시행하였다. 혈청 amylase치는 U-SFR 및 S-SFR과 유의한 양의 상관관계를 보였으며, 침샘 스캔 검사에서 귀밑샘의 분출분획이 높을수록 혈청 amylase치가 증가하였다. 그러나, 혈청 amylase와 질병 활성도 표지자 및 염증 표지자 결과는 상관관계를 보이지 않았다. 혈청 amylase 평균치를 기준으로 두 군으로 나누어 분석한 결과, 혈청 amylase치가 높은 환자 군에서 S-SFR과 귀밑샘 분출 분획이 통계적으로 유의하게 증가되어 있었다. 결론적으로, 혈청 amylase는 침 분비 능과 침샘 스캔 검사에서 귀밑샘의 분출 분획과 유의한 상관관계를 보여 쇼그렌 증후군에서 침샘 기능이 이상이 없다는 것을 시사하였다.

Keywords

Acknowledgement

This study was supported by the National Research Foundation of Korea (grant no. 2015R1C1A2A01054515).

References

  1. R. I. Fox, "Sjogren's syndrome", Lancet, Vol.366, pp.321-331, Jul. 2005. DOI: https://doi.org/10.1016/S0140-6736(05)66990-5
  2. P. Youinou, J. O. Pers, "Primary Sjogren's syndrome at a glance today", Joint Bone Spine, Vol.82, No.2, pp.75-76, Jan. 2015. DOI: https://doi.org/10.1016/j.jbspin.2014.10.018
  3. A. A. Bookman, H. Shen, R. J. Cook, D. Bailey, R. J. McComb, et al, "Whole stimulated salivary flow: correlation with the pathology of inflammation and damage in minor salivary gland biopsy specimens from patients with primary Sjogren's syndrome but not patients with sicca", Arthritis Rheum, Vol.63, No.7, pp.2014-2020, Jul. 2011. DOI: https://doi.org/10.1002/art.30295
  4. F. Vinagre, M. J. Santos, A. Prata, J. Canas da Silva, A. I. Santos, "Assessment of salivary gland function in Sjogren's syndrome: the role of salivary gland scintigraphy", Autoimmun Rev, Vol.8, No.8, pp.672-676, 2009. DOI: https://doi.org/10.1016/j.autrev.2009.02.027
  5. B. A. Fisher, R. M. Brown, S. J. Bowman, F. Barone, "A review of salivary gland histopathology in primary Sjogren's syndrome with a focus on its potential as a clinical trials biomarker", Ann Rheum Dis, Vol.74, No.9, pp.1645-1650, Sep. 2015. DOI: https://doi.org/10.1136/annrheumdis-2015-207499
  6. J. Y. Jung, C. H. Suh, "Update of Sjogren's Syndrome", Journal of Rheumatic Diseases, Vol.22, No.3, pp.146-153, 2015. DOI: http://dx.doi.org/10.4078/jrd.2015.22.3.146
  7. F. G. M. Kroese, E. A. Haacke, M. Bombardieri, "The role of salivary gland histopathology in primary Sjogren's syndrome: promises and pitfalls", Clin Exp Rheumatol, Vol.36, Suppl.112, No.3, pp.S222-S233, Aug. 2018.
  8. C. A. Burtis, E. R. Ashwood, D. E. Bruns, Tietz Textbook of Clinical Chemistry and Molecular Diagnostics, p.2238, ELSEVIER, 2012, pp.583-585.
  9. E. Magid, K. Frost-Larsen, H. Isager, R. Manthorpe, J. U. Prause, "Serum isoamylases in Sjogren's syndrome. Concentration levels and intra-individual variation", Scand J Rheumatol, Vol.12, No.2, pp.129-132, 1983. DOI: http://dx.doi.org/10.3109/03009748309102898
  10. R. O. Wolf, M. E. Ross, T. M. Tarpley, "Changes in serum salivary isoamylases in Sjogren's Syndrome", Am J Clin Pathol, Vol.65, No.6, pp.1022-1025, 1976. DOI: https://doi.org/10.1093/ajcp/65.6.1022
  11. L. Sreebny, W. X. Zhu, "Whole saliva and the diagnosis of Sjogren's syndrome: an evaluation of patients who complain of dry mouth and dry eyes. Part 1: Screening tests", Gerodontology, Vol.13, No.1, pp.35-43, Jul. 1996. DOI: https://doi.org/10.1111/j.1741-2358.1996.tb00148.x
  12. W. A. van der Reijden, J. S. van der Kwaak, E. C. Veerman, A. V. Nieuw Amerongen, "Analysis of the concentration and output of whole salivary constituents in patients with Sjogren's syndrome", Eur J Oral Sci, Vol.104, No.4 (Pt 1), pp.335-340, Aug. 1996. DOI: https://doi.org/10.1111/j.1600-0722.1996.tb00088.x
  13. O. H. Ryu, J. C. Atkinson, G. T. Hoehn, G. G. Illei, T. C. Hart, "Identification of parotid salivary biomarkers in Sjogren's syndrome by surface-enhanced laser desorption/ionization time-of-flight mass spectrometry and two-dimensional difference gel electrophoresis", Rheumatology (Oxford), Vol.45, No.9, pp.1077-1086, Sep. 2006. DOI: https://doi.org/10.1093/rheumatology/kei212
  14. C. Vitali, S. Bombardieri, R. Jonsson, H. M. Moutsopoulos, E. L. Alexander, et al, "Classification criteria for Sjogren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group", Ann Rheum Dis, Vol.61, pp.554-558, 2002. DOI: http://dx.doi.org/10.1136/ard.61.6.554
  15. A. Almstahl, M. Wikstrom, "Electrolytes in stimulated whole saliva in individuals with hyposalivation of different origins", Arch Oral Biol, Vol.48, pp.337-344, 2003. DOI: https://doi.org/10.1016/S0003-9969(02)00200-5
  16. R. Seror, E. Theander, J. G. Brun, M. Ramos-Casals, V. Valim, et al, "Validation of EULAR primary Sjogren's syndrome disease activity (ESSDAI) and patient indexes (ESSPRI)", Ann Rheum Dis, Vol.74, pp.859-866, 2015. DOI: http://dx.doi.org/10.1136/annrheumdis-2013-204615
  17. H. Flink, A. Tegelberg, F. Lagerlof, "Influence of the time of measurement of unstimulated human whole saliva on the diagnosis of hyposalivation", Arch Oral Biol, Vol.50, No.6, pp.553-559, 2005. DOI: https://doi.org/10.1016/j.archoralbio.2004.10.015
  18. M. Tishler, I. Yaron, I. Shirazi, M. Yaron, "Saliva: an additional diagnostic tool in Sjogren's syndrome", Semin Arthritis Rheum, Vol.27, No.3, pp.173-179, Dec. 1997. DOI: http://dx.doi.org/10.1016/s0049-0172(97)80017-0
  19. C. H. Shiboski, S. C. Shiboski, R. Seror, L. A. Criswell, M. Labetoulle, et al, "2016 American College of Rheumatology/European League Against Rheumatism Classification Criteria for Primary Sjogren's Syndrome: A Consensus and Data-Driven Methodology Involving Three International Patient Cohorts", Arthritis Rheumatol, Vol.69, No.1, pp.35-45, Jan. 2017. DOI: http:/dx.doi.org/10.1002/art.39859
  20. M. A. Javaid, A. S. Ahmed, R. Durand, S. D. Tran, "Saliva as a diagnostic tool for oral and systemic diseases", J Oral Biol Craniofac Res, Vol.6, No.1, pp.67-76, 2016. DOI: http://dx.doi.org/10.1016/j.jobcr.2015.08.006
  21. M. Arce-Franco, M. Dominguez-Luis, M. K. Pec, C. Martinez-Gimeno, P. Miranda, et al, "Functional effects of proinflammatory factors present in Sjogren's syndrome salivary microenvironment in an in vitro model of human salivary gland", Sci Rep, Vol.7, No.1, pp.11897, Sep. 2017. DOI: http://dx.doi.org/10.1038/s41598-017-12282-x
  22. O. H. Ryu, J. C. Atkinson, G. T. Hoehn, G. G. Illei, T. C. Hart, "Identification of parotid salivary biomarkers in Sjogren's syndrome by surface-enhanced laser desorption/ionization time-of-flight mass spectrometry and two-dimensional difference gel electrophoresis", Rheumatology (Oxford), Vol.45, No.9, pp.1077-1086, Sep. 2006. DOI: http://dx.doi.org/10.1093/rheumatology/kei212
  23. C. Baldini, L. Giusti, F. Ciregia, Y. D. Valle, C. Giacomelli, et al, "Proteomic analysis of saliva: a unique tool to distinguish primary Sjogren's syndrome from secondary Sjogren's syndrome and other sicca syndromes", Arthritis Res Ther, Vol.13, No.6, pp.R194, 2011. DOI: http://dx.doi.org/10.1186/ar3523
  24. A. Becciolini, G. Giannardi, L. Cionini, S. Porciani, C. Fallai, et al, "Plasma amylase activity as a biochemical indicator of radiation injury to salivary glands", Acta Radiol Oncol, Vo.23, No.1, pp.9-14, 1984. DOI: https://doi.org/10.3109/02841868409135978
  25. M. D. Leslie, S. Dische, "Changes in serum and salivary amylase during radiotherapy for head and neck cancer: a comparison of conventionally fractionated radiotherapy with CHART", Radiother Oncol, Vol.24, No.1, pp.27-31, 1992. DOI: https://doi.org/10.1016/0167-8140(92)90350-4
  26. B. Pal, I. D. Griffiths, A. Katrak, D. Junglee, P. Dandona, "Salivary amylase and pancreatic enzymes in Sjogren's syndrome", Clin Chem, Vol.33, No.2 (Pt 1), pp.305-307, 1987. https://doi.org/10.1093/clinchem/33.2.305
  27. T. Sumii, B. Ando, K. Sakai, "Chronic pancreatitis and pancreatic dysfunction associated with Sjogren's syndrome", Nihon Rinsho, Vol.53, No.10, pp.2525-2529, 1995.
  28. P. Afzelius, E. M. Fallentin, S. Larsen, S. Moller, M. Schiodt, "Pancreatic function and morphology in Sjogren's syndrome", Scand J Gastroenterol, Vol.45, No.6, pp.752-758, Jun. 2010. DOI: https://doi.org/10.3109/00365521003642542
  29. C. C. Chang, Y. S. Chang, S. H. Wang, S. Y. Lin, Y. H. Chen, et al, "Primary Sjogren's syndrome and the risk of acute pancreatitis: a nationwide cohort study", BMJ Open, Vo.7, No.8, pp.e014807, 2017. DOI: https://doi.org/10.1136/bmjopen-2016-014807
  30. S. B. Jensen, A. Vissink, "Salivary gland dysfunction and xerostomia in Sjogren's syndrome", Oral Maxillofac Surg Clin North Am, Vol.26, No.1, pp.35-53, Feb. 2014. DOI: https://doi.org/10.1016/j.coms.2013.0